Will this tool change the way TB is treated?
![](https://assets.weforum.org/article/image/large_TPfP47Kd7F4i4O51gqP6Y-FkNfZQ4g3LNyk8NcoOsKk.jpg)
Image: Clinical lead Doctor Al Story points to an x-ray showing a pair of lungs infected with TB (tuberculosis). REUTERS/Luke MacGregor
![A hand holding a looking glass by a lake](/uplink.jpg)
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Future of Global Health and Healthcare
Tuberculosis is the second-most common cause of mortality from an infectious disease in the world, killing nearly three people every minute.
While it is generally a curable disease—it first must be diagnosed, and that has been one of the biggest barriers in its elimination. M. tuberculosis grows slowly, so traditional methods of diagnostic testing and determining if treatments are working both take a very long time.
Now, a new method, reported in PLOS ONE, is able to detect whether a potential treatment is working as early as a day after it is given.
“Since M. tuberculosis takes about a month to quantify using traditional approaches, any method that allows direct determination of the amount of bacteria present is very valuable and speeds progress, saving months every time an experiment is done,” says Jeffrey Cirillo, a professor at the Texas A&M Health Science Center. “Our methods allow this.”
Cirillo’s previous research has focused on developing a rapid yet inexpensive test for tuberculosis. He and colleagues have nearly perfected the technology and are in the process of bringing the test to market.
Using optical imaging technology, the researchers can observe the bacteria in real time, in living animals, without harming them. This way, it is easy to determine if a proposed treatment is working and the number of bacteria is decreasing.
“There have never been sensitive enough systems to measure the bacteria directly in animals,” Cirillo says. “This is a completely new technology and has nearly limitless applications to microbiological research, particularly in animals, but it increases sensitivity in any experimental system.”
Drug-resistant tuberculosis, now present everywhere in the world, is hampering efforts to fight the disease because the usual drugs used to treat it are no longer effective. Therefore, new, more effective treatments need to be developed.
The researchers first had to find the best fluorescent protein to help them visualize the bacteria.
“We use very sensitive systems that can actually see the signal through mammalian tissue,” Cirillo says. “This works best in the near-infrared, which is where our signals are primarily produced.”
Active TB causes symptoms such as cough, fever, night sweats, and weight loss. If left untreated—a common scenario in developing countries lacking health care infrastructure—a person with active TB has only a 50 percent chance of survival, can infect an average of 10 to 15 people each year.
“The goal in TB research is complete eradication of the disease,” Cirillo says. “We think this new technology is one tool to do just that.”
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Fourth Industrial RevolutionSee all
Matthias Rebellius
August 23, 2024
Emma Charlton
August 22, 2024
Philipp Carlsson-Szlezak and Paul Swartz
August 15, 2024
Pamposh Raina
August 6, 2024
Fariz Jafarov
July 31, 2024